1: http://www.dh.gov.hk/tc_chi/statistics/statistics_hs/files/Health_Statistics_pamphlet_TC.pdf. Access on 18 Dec 2017 |
|
2: Drew BS, Dixon AF, Dixon JB. Obesity management: Update on orlistat. Vascular Health and Risk Management 2007:3(6) 817–821 |
|
3: The Asia-Pacific perspective: Redefining obesity and its treatment. Health Communication Australia Pty Ltd; 2000 |
|
4: 你是否過胖? http://www.chp.gov.hk/files/pdf/2565_are_you_obese_tc.pdf. Access on 18 Dec 2017 |
|
5: Arch Intern Med 2002;162:2428-2435 |
|
6: XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study |
|
7: http://www21.ha.org.hk/smartpatient/MiniSites/en-US/bmi/Ideal-BMI/Accessed on 26 Mar2018 |
|
8: http://www.diabetes-hk.org/ch/page/%E9%81%8B%E5%8B%95%E6%B2%BB%E7%99%82%20-%20%E9%AB%94%E9%87%8D%E6%8E%A7%E5%88%B6. Access on 18 Dec 2017 |
|
9: https://restaurant.eatsmart.gov.hk/b5/content.asp?content_id=378. Access on 18 Dec 2017 |
|
10: http://www.emedexpert.com/facts/orlistat-facts.shtml. Access on 18 Dec 2017 |
|
11: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process. Access on 18 Dec 2017 |
|
12: https://www.drugoffice.gov.hk/eps/drug/productDetail/en/consumer/95111. Access on 18 Dec 2017 |
|
13: IMS sales data 2017 (ATC III: A08A) |
|
14: https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm180076.htm Accessed on 26 Mar 2018 |
|
15. https://livertox.nih.gov/Phentermine.htm. Access on 18 Dec 2017 |
|
16. Xenical Hong Kong prescribing information, March 2015 |
|
17. https://livertox.nlm.nih.gov/Orlistat.htm. Access on 18 Dec 2017 |